Page last updated: 2024-08-23

4-boronophenylalanine and Carcinoma

4-boronophenylalanine has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabrini, R; Casal, M; Crivello, M; Dagrosa, MA; Juvenal, GJ; Kahl, S; Perona, M; Pisarev, MA; Pozzi, E; Santa Cruz, GA; Thomasz, L; Thorp, S1
Braun, I; Braun, K; Corban-Wilhelm, H; Debus, J; Ehemann, V; Eisenmenger, A; Heckl, S; Jenne, J; Pipkorn, R; Rastert, R; Waldeck, W; Wolber, G1

Other Studies

2 other study(ies) available for 4-boronophenylalanine and Carcinoma

ArticleYear
First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
    International journal of radiation oncology, biology, physics, 2011, Jan-01, Volume: 79, Issue:1

    Topics: Boron Compounds; Boron Neutron Capture Therapy; Carcinoma; Cell Line, Tumor; Cell Survival; Cobalt Radioisotopes; Colonic Neoplasms; Deuteroporphyrins; DNA Damage; Gamma Rays; Humans; Micronuclei, Chromosome-Defective; Micronucleus Tests; Nuclear Reactors; Phenylalanine; Radiation-Sensitizing Agents; Relative Biological Effectiveness

2011
The enhancement of neutron irradiation of HeLa-S cervix carcinoma cells by cell-nucleus-addressed deca-p-boronophenylalanine.
    European journal of medicinal chemistry, 2003, Volume: 38, Issue:6

    Topics: Active Transport, Cell Nucleus; Amino Acid Sequence; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma; Cell Nucleus; Cell Survival; Female; Flow Cytometry; HeLa Cells; Humans; Mass Spectrometry; Microscopy, Confocal; Molecular Sequence Data; Phenylalanine; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms

2003